Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07263594 · ClinicalTrials.gov registry record · Phase 1
A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
A Phase 1 study, sponsored by DualityBio.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 127
- Enrollment target
NCT07263594: Recruiting Phase 1 study, sponsored by DualityBio.
NCT07263594 is a Phase 1 study that is actively recruiting participants, run by DualityBio. The registered enrollment target is 127 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (112% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07263594, a Phase 1 study, is actively recruiting participants, sponsored by DualityBio.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 127 participants
- Enrollment target
Study Summary
This study, the first clinical trial, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of DB-1324.
Primary Outcome
Percentage of participants in dose escalation and backfill parts with DLTs
Interventions
- DRUG DB-1324
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2026-01-20 |
| Est. Completion | 2028-12 |
| Phase | Phase 1 |
What NCT07263594 shows while recruiting
NCT07263594 is an interventional study that assigns participants to a tested intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (112% higher).
The record links to 0 conditions, and to 1 intervention - of which DB-1324 is the first listed.
NCT07263594 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07263594 about?
NCT07263594 is a clinical study titled "A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors". This study, the first clinical trial, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of DB-1324.
What is the current status of trial NCT07263594?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 127 participants. The study started on 2026-01-20. Estimated completion is 2028-12.
What interventions are being tested in trial NCT07263594?
The interventions under investigation include: DB-1324 (DRUG).
Who is sponsoring clinical trial NCT07263594?
This trial is sponsored by DualityBio, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07263594's enrollment target sits among peer trials
127 459th of 2000 higher than 1,540 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03017820 · 127 participants · Phase 1
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
- NCT03609580 · 127 participants · Phase 1
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
- NCT06285643 · 127 participants · Phase 2
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- NCT06809400 · 127 participants · Phase 1
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI